Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · Supply Constraints · Earnings Surge / 2026-05-11 Research
  • [Research] Samsung SDI (006400) – IBK Securities | Accelerating North American ESS Conversions · FY26 AMPC KRW 359B · 4Q In Line / 2026-02-03 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · ADR Listing · Valuation Re-rating / 2026-03-23 Research
  • [Research] Samsung Biologics (207940) – Hana Securities | Rockville Acquisition Finalized · Guidance Revision Outlook · Tariff Resilience / 2026-04-02 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | Capacity Cannibalization · 1-Year LTA · Pricing Power / 2026-07-06 Research
  • [Research] LIG D&A (079550) – Yuanta Securities | Cheongung-II Demand Surge · OPM Guidance Upgrade · Middle East Overlap / 2026-08-07 Research
  • [Research] Alteogen (196170) – Hana Securities | ALT-B4 Differentiation Potential · Enhanze Biosimilar Concerns Dispelled · Qlex Revenue Visibility / 2026-07-15 Research
  • [Research] Alteogen (196170) – Hana Securities | New ALT-B4 Deal Signed · Qlex Prescription Surge · SC Conversion Acceleration / 2026-08-06 Research

[Research] Hanwha Ocean (042660) – DS Investment & Securities | Low-Price Mix Reduction · Merchant Margin Step-Up · MASGA & Defense Pipeline / 2026-04-28

Posted on April 28, 2026August 22, 2026 By ksb220805@gmail.com

Brokerage : DS Investment & Securities

Analyst : Daesung Kim

Investment Rating : BUY (Maintained)

Target Price : KRW 170,000 (Raised)

Core Momentum : Sustained commercial shipbuilding profitability driven by the declining share of low-margin legacy orders and TOP cost reductions, coupled with emerging growth catalysts from the US NGLS conceptual design contract and the CPSP/FPSO bidding pipeline

📊 1. [Valuation & Key Financial Metrics]

  • Rating & Target Price: BUY Maintained, Target Price raised to KRW 170,000 on upward revisions to earnings estimates (Current Price: KRW 133,500 as of April 27, 2026; Upside potential: 27.3%)
  • 1Q26 Earnings Summary: Revenue reached KRW 3.2 trillion (+2.1% YoY) and Operating Profit stood at KRW 385.2 billion (+70.6% YoY, OPM 13.7%), demonstrating an earnings surprise driven by commercial shipbuilding profitability.
  • Key Forecast Financials (2025 → 2026F → 2027F):
    • Revenue: KRW 12.78 trillion → KRW 13.82 trillion → KRW 15.90 trillion
    • Operating Profit: KRW 1.17 trillion → KRW 1.92 trillion → KRW 2.34 trillion
    • Operating Margin (OPM): 9.1% → 13.9% → 14.7%
    • Net Profit (Controlling): KRW 1.25 trillion → KRW 1.99 trillion → KRW 2.03 trillion
    • EPS: KRW 4,066 → KRW 6,487 (+59.5% YoY) → KRW 6,640 (+2.4% YoY)
    • PER: 27.9x → 20.6x → 20.1x
    • PBR: 5.6x → 5.3x → 4.2x
    • ROE: 22.6% → 28.7% → 23.4%
    • EV/EBITDA: 28.4x → 20.9x → 16.9x

🚀 2. [Market Opportunities & Business Outlook]

  • Merchant Vessel Margin Expansion: Despite 5 fewer working days QoQ, operating profit delivered a solid performance due to: 1) a lower mix of low-price 2022 orders (falling from 40% in 4Q25 to 20% in 1Q26), 2) tangible cost-saving impacts from the TOP (Total Operational Performance) program initiated in 2023, and 3) high LNGC revenue exposure (70% within commercial vessels). For full-year 2026, 2022 order exposure is projected to decline to 10%, while container ship exposure rises to 13%, securing solid mix improvement effects.
  • Special Ship & Offshore Segment Outlook: Both units posted operating losses in 1Q26 due to fixed-cost burdens following order deferrals. In special ships, active pipelines include KDDX and Thai frigates, with the preferred bidder selection for the Canadian CPSP expected in 1H26. For offshore, multiple tenders from Petrobras and TotalEnergies are slated for 2026 (led by Brazilian FPSOs), with securing 2 or more units expected to facilitate an early operating turnaround.
  • MASGA Progress in US Defense: Hanwha Ocean secured the conceptual design contract for the US Next Generation Logistics Ship (NGLS) program, securing an advantageous position for future series construction. Additional valuation re-rating potential remains intact via Medium Unmanned Surface Vessel (MUSV) pursuits and joint US naval shipbuilding opportunities via the Austal acquisition.

📝 Editor’s Comment (Perspective)

The analyst views Hanwha Ocean as a premier shipbuilder proving fundamental earnings quality improvements through legacy low-price order reduction and operational cost rationalization (TOP), while actively constructing a differentiated growth profile in North American naval defense (MASGA) following its US NGLS conceptual design contract win. This perspective prioritizes the structural earnings recovery in commercial shipbuilding and strategic positioning in the US defense supply chain over near-term fixed-cost pressures in the naval and offshore units.

To evaluate whether this investment thesis continues to materialize, key verification points include whether merchant operating margins continue to expand as 2022 legacy orders drop to 10% of revenue, the announcement of the preferred bidder for the Canadian CPSP submarine project alongside KDDX and Thai frigate contract awards, and definitive project awards for 2+ offshore FPSOs and subsequent US NGLS series build contracts. These factors can be tracked through upcoming quarterly earnings releases, official IR materials, regulatory filings, and periodic financial reports.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Shipbuilding

Post navigation

Previous Post: [Research] Hanwha Ocean (042660) – Hanwha | Merchant Margin Surprise · High-Price Mix Expansion · Special Ship Fixed-Cost Absorption / 2026-04-28
Next Post: [Research] Samsung SDI (006400) – SK Securities | Plant Utilization Recovery · North America ESS Expansion · AMPC Benefits / 2026-04-29

Related Posts

  • [Research] LIG D&A (079550) – Shinhan Securities | Structural Export Growth · Order Pipeline · Long-term Demand / 2026-08-07 Research
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | CAPEX Surge · Foreign Inflows · Target Price Upgrade / 2026-07-16 Research
  • [Research] Hanwha Ocean (042660) – Hana Securities | Merchant Vessel Margin Expansion · Energy Supply Chain Shift · Order Momentum / 2026-07-28 Research
  • [Research] Samsung SDI (006400) – Kiwoom Securities | ESS & BBU Momentum · Europe Market Share Recovery · 4Q26 Turnaround / 2026-04-29 Research
  • [Research] LIG D&A (079550) – Yuanta Securities | 4Q25 Review · Conservative 2026E Guidance · Long-term Structural Growth / 2026-02-19 Research
  • [Research] Samsung SDI (006400) – Shinhan Securities | US ESS Demand Surges · BBU Growth · 4Q26 Turnaround / 2026-04-29 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | Memory Pricing · Long-Term Contracts · HBM4 / 2026-01-14 Research
  • [Research] Samsung SDI (006400) – Mirae Asset | Operating Profit Upgrades · Core Turnaround · Prismatic Competitiveness / 2026-07-31 Research
  • [Research] Samsung Biologics (207940) – Hana Securities | Rockville Acquisition Finalized · Guidance Revision Outlook · Tariff Resilience / 2026-04-02 Research
  • [Research] SK hynix (000660 / SKHY) – Hana | LPDDR Demand · Mobile DRAM Tightness · Earnings Growth / 2026-04-24 Research
  • [Research] Samsung Biologics (207940) – Daishin Securities | Plant 5 Operation · Fixed-Cost Operating Leverage · Plant 6 Expansion / 2026-05-19 Research
  • [Research] Hanwha Ocean (042660) – SK Securities | Merchant Margin Growth · Offshore Order Requirements · Global Naval Pipeline / 2026-07-13 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Memory Pricing · Operating Leverage · Shareholder Returns / 2026-01-30 Research
  • [Research] Samsung Biologics (207940) – DS Investment & Securities | Plant 5 Revenue Contribution · US Plant Acquisition · Plant 6 Groundbreaking / 2026-04-23 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme